Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Grants
  • About Akademiliv
Rebecca Riise, Axel Nelson, Josefine Ekström, and Lars Ny are among those working on the clinical study involving a completely new method for cell therapy targeting secondary tumors in the liver.

SEK 10M awarded for study advancing cell therapy

7 February, 2024

GRANT. An automated system for mass-producing targeted white blood cells, with one billion T cells injected into liver tumors. Lars Ny and his research team secured a SEK 10 million grant from the Swedish Cancer Society, advancing cell therapy to new heights.

T lymphocytes, or T cells, play a pivotal role in the body’s immune system. These adaptive white blood cells can tailor their responses to specific threats, such as viruses or cancer cells.

Lars Ny, Professor of Immuno-oncology at the Institute of Clinical Sciences, is leading a study where cancer patients receive a novel cell therapy developed by researchers at the University of Gothenburg. The study targets the local treatment of secondary tumors (metastases) in the livers of patients with ocular melanoma.

Broad collaboration

“To receive such a substantial grant is incredible. Competition for funding in clinical treatment studies is exceptionally tough. The fact that we secured it indicates that the Swedish Cancer Society recognizes our expertise and the high quality of our work,” says Lars Ny.

Rebecca Riise isolates T cells (TILs) from a piece of the liver tumor. The work is conducted in the cleanroom at the Cell and Tissue lab.

“Ocular melanoma is rare, but researching it is crucial. Currently, there are no effective treatments that significantly impact survival once the disease has spread. Thanks to the grant, we have the freedom to conduct this study comprehensively. We can delve into analysis more profoundly than we could otherwise. We have the resources to engage all the necessary experts in our group. This fundamentally alters the conditions for implementing an advanced and innovative approach.”

The research project involves not only oncologists.

“We collaborate with various experts, including radiologists, surgeons, tumor biologists, and immunologists. This multidisciplinary teamwork is the key to success.”

A thousand cells become a billion

The study, conducted on six patients, aims to develop and evaluate a method for automated production of endogenous T cells (tumor-infiltrating lymphocytes, TILs), which are then injected into the tumor.

Samuel Alsén at the bioreactor, which automatically produces one billion T cells (TILs) over approximately two weeks. These cells are then directly injected into the tumor in the liver.

The process takes place in four steps:

  • A piece of the tumor is removed, and a few thousand T cells are isolated.
  • Manual cultivation for two weeks increases the T cell count to about one million.
  • Over the next two weeks, a machine automatically produces T cells, bringing the count to at least one billion.
  • Through a catheter inserted into the groin artery, a large number of T cells are injected directly into the tumor tissue in the liver.

Challenges with the method

What are the difficulties with this new method of cell therapy?

“Firstly, we need to manufacture the T cells according to all the established standards and meet the requirements of the Swedish Medical Products Agency. Also, ensuring the cells maintain their activity and remain free from contamination by bacteria or viruses is crucial,” says Lars Ny.

What are the potential risks for the patients involved in the study?

“The primary goal of the study is to confirm the safety of the treatment. When we introduce such a large number of cells into a small tissue area, there is a theoretical risk of bleeding and clots in the liver. However, in the initial treatments on the first patients, we haven’t observed anything of this nature.”

Primary cell culture of endogenous tumor-infiltrating lymphocytes (TILs) before the automated cell production in the bioreactor.

Competing immune cells

Other immune cells compete with the supplied T cells. It is crucial to fight these immune cells to prevent an inappropriate immune reaction in the body. This is partially prevented by patients receiving chemotherapy before the procedure.

“An essential aspect of this phase 1 study is gaining insights into how to design the subsequent clinical treatment study,” says Lars Ny.

If the study shows that the cell therapy has a good effect against metastases in the liver in patients with ocular melanoma, he envisions expanded possibilities in the future.

“This form of cell therapy might also prove relevant in other cancer types that spread to the liver, like skin melanoma and cancers of the colon or pancreas.”

BY: JAKOB LUNDBERG
The article was first published by the Institute of Clinical Sciences

 

 

By: Elin Lindström
Tagged With: Bidrag och stipendier, Cancerforskning, institutionen för kliniska vetenskaper

HAPPY SUMMER!

The newsletter from Akademiliv will return on Wednesday, August 21st.

Contact your institute to add your event to the calendar in the Staff Portal

  • Biomedicine: Kristian Kvint: kalender@biomedicine.gu.se
  • Core Facilities: Amelie Karlsson: amelie.karlsson.2@gu.se
  • Clinical Sciences: Katarina Olinder Eriksson: klinvet@gu.se
  • Medicine: Nina Raun; kommunikation@medicine.gu.se
  • Neuroscience and Physiology: Josefin Bergenholtz; kommunikation@neuro.gu.se
  • Odontology: Johan Thompson; info@odontologi.gu.se
  • Sahlgrenska Academy’s Office and faculty-wide calendar events Åsa Ekvall; info@sahlgrenska.gu.se
  • Health and Care Sciences: Karin Mossberg; vardvetenskap@fhs.gu.se

Information from Sahlgrenska Academy Research Support Office

[UPDATED JUNE 2024]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated on a monthly basis.
Current and previous newsletters are also available in the Staff Portal.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

More news

En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book

27 May, 2024

NEW BOOK. During his career as a physician specializing in internal medicine, Björn Fagerberg has been involved in many end-of-life situations, …  

She is doing her residency in the US with a medical degree from Gothenburg

21 May, 2024

STUDENT. Doing a “residency” in orthopedics in the United States is an unattainable dream for many newly qualified American doctors. Now Janina Ka …  

Alba Corell reports from a high-level brain tumor meeting

20 May, 2024

COLUMN. The recent gathering of the Scandinavian Society of Neuro-oncology (SNOG) in Gothenburg has concluded. Professor Asgeir Jakola hosted and …  

From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health

17 May, 2024

GLOBAL HEALTH. In the bustling Tygerberg University Hospital in Cape Town, a dedicated research team led by Lina Bergman, is on a mission to …  

Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024

17 May, 2024

AWARD. The Assar Gabrielsson Foundation has named Anna Wenger as the winner in the basic science research category and Sara Bjursten as the …  

A full day for PhD students focused on mental health

16 May, 2024

PHD STUDENTS. For the sixth time, PhD students at Sahlgrenska Academy were invited to PhD Day, organized by the Doctoral Student Council. The day …  

Kaj Blennow ranked highest in Sweden in neuroscience

16 May, 2024

AWARD. In this year's edition of the researcher ranking from Research.com in the field of neuroscience, Kaj Blennow is ranked 17th …  

Linda Wass is doing a postdoc at Stanford with ALF funding

14 May, 2024

ALF FUNDING. Biomedical Scientist Linda Wass has just settled in Stanford, California, where she will spend two years as a postdoc. She is the …  

Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023

14 May, 2024

AWARD. Karin Nilsson, currently a postdoc at the Department of Internal Medicine and Clinical Nutrition, receives the faculty-wide Thesis of the …  

Some answers from the proposed members of the next Faculty Board

14 May, 2024

FACULTY ELECTIONS. The eight proposed members of the next Faculty Board hereby give some brief answers on how they want to contribute to the work …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen